Fujifilm Cellular Dynamics announced that it opened a new headquarters and manufacturing facility in Madison, Wisconsin. The company expects its new site to quadruple its capacity for human-induced pluripotent stem cell (iPSC)-based research products and services manufacturing footprint. It also expects to expand capabilities across its research product portfolio. The new expansion comes as part…
Eli Lilly commits $4.5B to Indiana manufacturing sites, opens gene therapy plant
Eli Lilly (NYSE:LLY) announced today that it has committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S.,…
Thermo Fisher unveils new cell therapy manufacturing platform
Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts–based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…
AstraZeneca opens new API manufacturing plant in Dublin
AstraZeneca has officially opened its new active pharmaceutical ingredient (API) manufacturing facility in Dublin, Ireland. IDA Ireland, the foreign direct investment arm of the Irish government, said in a news release that the new facility brings advanced automation, AI and innovative new technologies into one place to continue to innovate in science and manufacturing. “Healthcare…
Novartis to build new API manufacturing plant in North Carolina
Novartis announced today that it plans to add a new active pharmaceutical ingredient (API) manufacturing plant in North Carolina. The company expects the facility in Morrisville to focus on APIs for solid dosage tablets, capsules and RNA therapeutics. Novartis said its new facility marks a critical step to strengthen end-to-end U.S. production capability. It comes…
West launches new drug delivery packaging solution
West Pharmaceutical Services (NYSE:WST) announced today that it launched its NovaPure 0.5 mL plunger for ISO glass syringes. Exton, Pennsylvania-based West designed the syringes to meet the performance and quality requirements for ophthalmic drug applications. The plunger is West’s newest ready-to-use elastomer component within the NovaPure portfolio. This includes the existing 1 mL and 1-3…
PCI to expand fill-finish capabilities
PCI Pharma Services announced that it made a series of infrastructure investments to deepen its sterile fill-finish and advanced drug delivery capabilities. Philadelphia-based PCI says its latest investments come as part of a broader commitment exceeding $1 billion. Its investment spans across its U.S. and European operations. The company hopes to provide seamless support for…
BD, Suttons Creek partner to support drug delivery combination products
BD (NYSE:BDX) announced today that it entered into a strategic, non-exclusive collaboration with Suttons Creek, a BlueRidge Life Sciences company. The companies aim to help pharmaceutical and biotech companies more efficiently navigate the engineering, testing, quality and regulatory complexity associated with combination product development. Under the collaboration, ZebraSci, BD’s device-agnostic combination product testing organization, is…
AbbVie to build $1.4B plant, create 730 jobs in North Carolina
AbbVie (NYSE:ABBV) today announced a $1.4 billion investment to build a new pharmaceutical manufacturing campus in Durham, North Carolina. The 185-acre campus will integrate advanced manufacturing and laboratory technologies with AI to support the production of AbbVie’s immunology, neuroscience and oncology medicines. It marks the latest significant investment in pharmaceutical manufacturing after the company outlined…
Kincell Bio to expand North Carolina manufacturing site
Kincell Bio announced that it made a significant strategic investment in the expansion of its Research Triangle Park, North Carolina, facility. The contract development and manufacturing organization (CDMO) supports autologous and allogenic cell therapy programs. It expects the new expansion to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval…